Types of corporate proposal Exercise of Warrants
Details of corporate proposal Exercise of Warrants
No. of shares issued under this corporate proposal 500,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.0500

Date Announced 27 Oct 2021

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3203922
-----------

It's looking good for the mother share price. Give a good indication on its future prospects.

@Peace99. I can't elaborate or give my concrete analysis on why the transaction was at 5 sen. I don't have the info on that.

But, from my simple observations, I like to conclude that Kanger WAS and STILL IN THE OPERATOR'S PLAY.


1. What are their objectives ?
I am not sure about it.

(a) Whether they are in the accumulation mode and will push the price after this?
or,

(b) Whether they are the operator/s who had accumulated a big amount of shares before the RI,
subscribing the RI or after the RI, and now just want to dispose their shares?

They maybe have TWO options:

- abandon the counter.

- accumulate shares @4.5 sen - 5.0 sen and later will push up the price.
This option is more possible based on the volume and the trend of buying @ 5 sen.

2. For whom/parties they are playing for ?

Still a mystery.

But, no announcement has been done rferring to disposal of shares from substantial share holders.

Therefore I concluded that:

1. The operator/s are not playing for the three substantial shareholders.

2. The operator/s maybe playing for the big shareholders (but not a substantial holders) or several
small operators / sharks are in play in this counter.

JUST MY 2 SEN ANALYSIS ONLY. TAYOR

@pineapple123. The report of the investment on quoted shares, including BSL shares.

Its showed that as at 25 Oct 2021, the investment in quoted shares are profitable to the company.
.................

OTHERS BCM ALLIANCE BERHAD ("BCM") DEALINGS IN QUOTED SECURITIES UNDER RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3203769

Basis and justification of determining the issue price and Rights Shares

The issue price of the Rights Shares will be determined and fixed by the Board at a later date after receipt of all relevant approvals and after taking into consideration, amongst others, the following:-

i. the prevailing market conditions and market prices of Techfast Shares;

ii. the theoretical ex-rights price of Techfast Shares ("TERP") based on the 5-day
VWAP of Techfast Shares immediately preceding the price-fixing date; and

iii. Accordingly, the Board will fix the issue price of the Rights Shares at no less than RM0.12 each in order to achieve the said minimum amount to be raised from the Proposed Rights Issue with Warrants after taking into consideration the prevailing market conditions and market prices of Techfast Shares at the price-fixing stage, subject to a maximum allowable discount of not more than 50% to the TERP of Techfast Shares based on the 5-day VWAP of Techfast Shares immediately preceding the price-fixing date.

ESOS Options : A total of up to 104,908,225 option(s) to subscribe for Techfast Shares to
be granted to the Eligible Person(s) pursuant to the ESOS.

As at the LPD:-
(i) 46,816,480 options had been exercised at the exercise price of RM0.3204 each on 22 April 2021;

(ii) 8,573,388 options had been exercised at the exercise price of RM0.2916 each on 10 June 2021; and

(iii) 49,518,357 options that may be granted and exercised

Anyway, let us look at the three questions for us to get the answers:

Before the RI, the operators pushed down the price to the bottom.
Three big questions need the answers:

1. Now, are they trying to push up the price or pushed down the price?
Currently, the answer is they are pushing down the price.

Therefore:
To what price they intend to push down the price?

2. Are they planning to opt out from this counter later?

3. What will the three substantial share holders do about the Kanger share price?

@zzzzzzz. Ya lah. Nanti keluar hantu pocong. He He

wistlebower99. ... This is your advice.....

---- Better take a break for few months wait to see any improvement to quarterly financial results.
--+++++++++++

But you keep pissing your venom in this counter!!!!
What an ill intention spammer you are.... He He

Wistlebower99.

ANYWAY, KANGER WAS MORE DIVERSIFIED.

In near future, we should concern more on these potentials of the company:


1. The proceed from the disposal of assets (if done) will give positive short term impact on profitability of Kanger.

2. Expecting the expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future. The businesses should be improved when the Covid-19 pandemic settles in the near future.

3. The contribution from Sung Master also expected to help Kanger in terms of increasing the company's revenue and profitability in the near future.

Yes. It's my two sen prediction only.

@wistlebower99. Won't let you freely pissing your venom in this counter!!!!

We won't follow your ill-intention advice.. He He

@Gtrade. Orang tanya lain, awak jawab lain.... He He

The facts are:

1. It's not a MUST for the company to do consolidation, even when its NOSH is already huge.

2. Its should be OKAY for the company to do some types of share issuances, IF the objective of the issuance of shares is to collect fund for the betterment of the company, such as for financing the new good investments.

3. Even the good company such as MyEg needs to issue new shares in collecting new fund. Therefore, using the said method to collect fund for new investment in Kanger, I think also a JUSTIFIABLE exercise.

TAYOR

@jayden007. I think the company will set the issue price for the RI around 12 sen - 20 sen only. Just my guessing . TAYOR

MyEG plans private placement to raise as much as RM309mil

KUALA LUMPUR (Bernama) -- MyEG Services Bhd (MyEG) has proposed placement of up to 4.17% of its total number of issued shares to third party investors that would be identified later at an issue price to be determined later.

It said as of the latest practicable date, the total issued share of MyEG is valued at RM664.24 million comprising 7.38 billion shares, including 182 million treasury shares.

Source: https://www.klsescreener.com/v2/news/view/896503/myeg-plans-private-placement-to-raise-as-much-as-rm309mil

------------

GTrade and wistlebower99. What is your comment on MyEg's proposed PP?

The NOSH of the company already 7.38 billion units.

What is the probability for MyEg to do the consolidation?
Is it high or low ? He He

zzzzzzz. Hantu pocong sudah keluar ke?
Jaga-jaga. He He

Que buy some WB @0.5 sen.
In case there are some investors still want to dumb the warrant. 0.5 sen, it's very cheap, I think.
He He.

Yes. As I posted before.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

and:

Kanger will collaborate with ZP to facilitate the import, warehousing, and distribution of Covid-19 vaccines in Malaysia. "

Just for info.

For Duopharma case on COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated

Holder : DUOPHARMA (M) SDN. BHD.
Importer : DUOPHARMA (M) SDN. BHD.
Manufacturer : Beijing Institute of Biological Products Co., Ltd. (BIBP)

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

-----------------
Which party could be named as the importer in Kanger's application with NPRA for Hayat-Vaxx vaccine ??

Its okay. Thank you.

Chill dear friend. There are to many people who want to throw spanner here. Why you're so mad???

@Noobie123. Will you give us the website address under NPRA website which has a list of importers, other than the said NPRA website address.

Will you please. It's good for confirmation on this issue.

@Noobie123. The list from NPRA shoud cover importers.

Please examine the site, where Kanger Medical International was listed.

............... quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

Full website address:

www.npra.gov.my/index.php/en/informationen/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

@Noobie123. The license category listed for Kanger Medical International Sdn Bhd
is A. Category:A - Poison

--------------

Category: A, I think the highest level of license. Should cover vaccine. Please correct me if I am wrong.

------------------
Look at all the listed categories:

A- Poison; X-Non Poison; TM-Traditional; HS-Health Supplement; TMHS-Traditional & Health Supplement; Vet-Veterinary

@JK22. Thank you very much. It is true that Kanger Medical is on the NPRA list of Licensed Wholesalers in QUEST System !!!!

For members to check.

1. Please browse:

www.npra.gov.my/index.php/en/informationen/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

2. “search” for Kanger Medical – and its should be there!!!

It’s a confirmation that Kanger is doing hard enough to secure the NPRA aproval for the Hayat-Vax vaccine.

@mansaham1972. Bagi saya positif saja. Kalau BOD senyap saja, dan hanya bergantung pada perniagaan BAMBOO di China, sedangkan perniagaan bamboo pada masa itu dalam proses perpindahan kilang dan penjualan (termasuk eksport) terjejas teruk akibat Covid-19 adakah awak fikir Kanger BERDAYA MAJU.

Saya sokong plan dan usaha Kanger untuk diversify perniagaan, terutama dalam perniagaan yang ada peluang daya maju.

Memang bukan semua plan perniagaan semestinya dapat dilaksanakan seperti dirancang. Namun, sebagai USAHAWAN, saya sokong BOD Kanger yang saya anggap bijak cuba mengambil peluang.

@Noobie123

Referring to the announcement by Kanger:

----- "The Board of Directors of Kanger wishes to announce that the Company is still waiting for the approval from National Pharmaceutical Regulatory Agency (NPRA)."
-------------

The announcement by the listed company should be binding by Law and Regulations.

I think, they could not simply say that ".... is still waiting for the approval..." if they do not applied for the approval yet. It will be misleading information given to the investors and public and the BOD will has a risk of breaching the law.... I think the BOD not dare to take the risks.

Therefore, I concluded that, Kanger has submitted the application for NPRA approval.

TRUE, the NPRA has their justifications to be fulfilled before approving the application.

Even the Sputnik V not yet approved by NPRA. INI MASALAH ROTI CANAI, NIE.. He He

@Noobie123. ... need to have Manufacturer’s Licence, Import Licence or Wholesale Licence.
------------

Just to share my notes on the proposed business.
BUT I'm NOT SURE about the TRUE SITUATION that happened in the company's plans and business. TAYOR



" Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

and:

Kanger will collaborate with ZP to facilitate the import, warehousing, and distribution of Covid-19 vaccines in Malaysia. "

Sinopharm (Beijing): BBIBP-CorV (Vero Cells) Vaccine Type: Inactivated.
This vaccine may also be referred to as Covilo. – This vaccine is approved by NPRA and registered by Duopharma as a registered holder.

This vaccine is also manufactured by G42 Healthcare (Hayat-Vax), the vaccine that Kanger is waiting for the approval from NPRA.

Source: https://covid19.trackvaccines.org/vaccines/5/

KUALA LUMPUR (August 14, 2021 ) : The United Arab Emirates (UAE) has donated 1 million doses of Covid-19 vaccine to Malaysia to combat the pandemic.

Expressing his gratitude, Senior Foreign Minister Datuk Seri Hishammuddin Hussein said the contribution would greatly assist in intensifying the daily vaccination rate of the Covid-19 National Immunisation Programme (NIP).

"The Foreign Ministry welcomes the contribution of 1,000,000 doses of vaccine by the Government of UAE to Malaysia.

"On behalf of His Majesty the Yang di-Pertuan Agong, the Government of Malaysia, and the Malaysian people, I would like to express our sincerest gratitude to His Highness Sheikh Mohamed Zayed Al-Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces; my counterpart, His Highness Sheikh Abdullah Zayed Al-Nahyan, Foreign Affairs and International Cooperation Minister.

Source: https://www.nst.com.my/news/nation/2021/08/717928/uae-donates-1-million-doses-covid-19-vaccine-malaysia

---------------------

I can not get further news about this UAE donation. Any news about it ?

Reference is made to the announcement dated 19 July 2021 pertaining to the Head of Agreement between Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company and Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

The Board of Directors of Kanger wishes to announce that the Company is still waiting for the approval from National Pharmaceutical Regulatory Agency (NPRA).

This announcement is dated 18 October 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3201776

ANYWAY, KANGER WAS MORE DIVERSIFIED.

In near future, we should concern more on these potentials of the company:


1. The proceed from the disposal of assets (if done) will give positive short term impact on profitability of Kanger.

2. Expecting the expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future. The businesses should be improved when the Covid-19 pandemic settles in the near future.

3. The contribution from Sung Master also expected to help Kanger in terms of increasing the company's revenue and profitability in the near future.

@wistlebower99. Better check if someone is sleeping on the job

--------------------
Both documents should be looked as official documents. The company or BOD should be legally liable on their reports.

Bare in mind, that there should be are variabilty on the tentative of the projects. Only they know what happened.

The status for another CA on construction projects. See remarks.
-----------

5. A Collaboration Agreement between Kanger Ventures and Multiple Novation, relating to a multiple constructions works.

Progress of the agreement:

a. Based on an announcement at BURSA dated 15 January 2021

The Board of Directors of Kanger International wishes to announce that its wholly-owned subsidiary, Kanger Ventures Sdn Bhd , had on 15 January 2021 entered into the following Collaboration Agreements.

a) Qbeez Holdings Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 6th July 2018 for construction of main building works of the project of development of three (3) blocks of affordable apartment on Lot 52957, Jalan Desa, Taman Desa, Mukim Kuala Lumpur, Wilayah Persekutuan (“Qbeez Project 1”);

b) Qbeez Holdings Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 28th December 2018 for construction of building and external works for the project of development two (2) blocks apartment on PT 15659, Jalan Indrahana 3, Mukim Petaling, Kuala Lumpur, Wilayah Persekutuan (“Qbeez Project 2”);

c) Lead Pinnacle Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 28th October 2019 for construction of piling and foundation works of the project of construction of a temporary gallery on PT 23923, (H.S.(D) 18603) Genting Highlands, Mukim Bentong, Daerah Bentong, Negeri Pahang (“Lead Project 1”);

d) Lead Pinnacle Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 7th July 2020 for construction of foundation and main building works for the project of a mixed development of two (2) blocks of service apartment on PT 23923, (H.S.(D) 18603) Genting Highlands, Mukim Bentong, Daerah Bentong, Negeri Pahang (“Lead Project 2”);

e) Deseo Engineering Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 13th April 2018 for construction of main building works for the project of a development of two (2) blocks of affordable apartments and two (2) blocks of apartment on Lot 55121, Jalan Jujur, Bandar Tun Razak, Cheras, Kuala Lumpur (“Deseo Project”);


f) Enduring Power Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 1st June 2019 for construction of main building works for the project of a development of two (2) blocks of service apartment on Lot 1351 & 1377, Jalan Padang/Jalan Padang Walter Grenier dan sebahagian simpanan Jalan, Seksyen 67, Bukit Bintang, Bandar Kuala Lumpur (“Enduring Project”).



Any approval required from the relevant authority and shareholders in a general meeting of the Company to undertake this collaboration herein contemplated;

The Parties shall fulfill the above conditions within 90 (ninety) days from the date of these agreements or such extended date as shall be mutually agreed in writing by the Parties (Cut-Off Date).


Remark:

1. No further announcement on the progress of this Collaboration Agreement or any termination of the CA yet by to date.

@Patience99. For now, only this construction project should be under commencement.

1. A Collaboration Agreement between Vegetta Champion Sdn. Bhd. and Kanger Ventures Sdn. Bhd. a wholly owned subsidiary of Kanger, relating to a Genting Highland construction project contract with contract value RM478 million.

Progress of the agreement:

a. Based on an announcement at BURSA dated 2 March 2021.

VCSB received a Letter of Intent dated 2 March 2021, whereby VCSB was appointed as the main contractor for foundation and main building works of a project.

Kanger Ventures shall be responsible for the entire project management, financial and entire administration of the Project

b. Based on an announcement at BURSA dated 4 March 2021.

The Company announced that the Project is expected to commence in June 2021 and to be completed in 48 Months.


Remark: The construction project contract under this collaboration agreement will start in June 2021.

@whistlebower99. .... MZM, which one is lying ?

----------------
But I don't think The Chairman of Kanger International is lying !!!!!!.

My source of facts: Chairman's Statement, in Kanger Annual Report 2021 page 20 stated this:

"Furthermore, in line with our aim to continuously seek for
suitable and viable acquisition opportunities in strategic
locations, the Group had also purchased 126 service
apartment units at Antara @ Genting Highlands on an enbloc
basis. Expected to be completed in 2024, we believe
that the rental income or capital gains arising from these
property units will contribute positively to the Group."


Source: Please download Kanger Annual Report 2021.pdf at:

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3189156

whistlebower99. ..... with expected completion by January 2026. ---- Wait 4 years to see results

-------------------------

Which facts is true ?

The Group had also purchased 126 service apartment units at Antara @ Genting Highlands on an enbloc basis. Expected to be completed in 2024.

-------------------

ANYWAY, KANGER WAS MORE DIVERSIFIED.

1. The proceed from the disposal of assets (if done) will give positive short term impact on profitability of Kanger.

2. Expecting the expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future. The businesses should be improved when the Covid-19 pandemic settles in the near future.

3. The contribution from Sung Master also expected to help Kanger in terms of increasing the company's revenue and profitability in the near future.

2. CORPORATE MILESTONES OF THE COMPANY IN 2021

 Diversified into new construction business aimed at deriving synergy with the property investment and management segment. Acquired 51% stake in building materials supplier, Sung Master Holdings Sdn Bhd for RM94.8 million. Acquired 126 units of service apartments at Antara @ Genting Highlands for RM142.87 million.

 One of the new subsidiaries, Kanger Medical International Sdn Bhd is making inroads into the healthcare industry by sourcing for face masks and Covid-19 vaccines.

MY COMMENTS:

a) These "corporate" statements give us the SIGN that the BOD and the company has tried to do some efforts for the betterment of the company in future.

b) The company are diversifying and also entering business activities in Malaysia, instead of solely relied on the PRC business activities. Some of the progress of diversification can be read below:

 Currently, the Group is working together with a few parties to complete multiple construction projects across a few sites in the state of Selangor and Pahang to the tune of approximately RM1.0 billion. The Group is also in the midst of applying for the Grade 7 contractor license from the Construction Industry Development Board (“CIDB”) and aims to tender for new construction projects to further grow our construction orderbook.

 The Group already completed the purchasing of a 51% stake in building materials supplier, Sung Master Holdings Sdn. Bhd. The acquisition will broaden the Group’s product offerings to also include other building materials such as timber, flooring, tiles, bulk cement, concrete, locksets and sanitary ware. This strategic acquisition is well-aligned to strengthen and complement the Group’s newly established construction business as Kanger will be able to source the building materials directly from Sung Master’s suppliers to better manage the input cost and enhance the profitability of these construction projects.

 The Group had also purchased 126 service apartment units at Antara @ Genting Highlands on an enbloc basis. Expected to be completed in 2024. The company believes that the rental income or capital gains arising from these property units will contribute positively to the company.

Some of the positive notes are as follows:

1. NEW ENGINES OF GROWTH FOR BAMBOO AND RELATED PRODUCTS
 In the fourth quarter of 2020, the construction of the company new bamboo concession and processing plant in Jingzhou was completed. Although the plant is still in the early phases of testing and commissioning, the company is looking forward to the positive financial contribution it will bring to the Group once commercial production commences.
 The expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future.

MY COMMENT:
a) The company has stated the promising progress has been made in the relocation of the new bamboo and processing plant. The company still keen on the potentials of its bamboo and related products business to be turn around especially after the new processing plant in Jinzhou started to operate.

Anyway, let us look at the three questions for us to get the answers:

Before the RI, the operators pushed down the price to the bottom.
Three big questions need the answers:

1. Now, are they trying to push up the price or pushed down the price?
Currently, the answer is they are pushing down the price.

Therefore:
To what price they intend to push down the price?

2. Are they planning to opt out from this counter later?

3. What will the three substantial share holders do about the Kanger share price?

TAYOR.

@r16688. ...when every body run away scared...i become GREEDY...ALL IN...SAI LANG...
------------
The brilliant idea has been poooop out from you. Bravo and good luck for us dear friend.

@JK22. What i trying to say is NOBODY in this forum know how , when , what will be the future movement of this counter. It is just everyone guess and hope. Some for bad , some for good. Listen only to your own self.
---------
Thanks, for your consolation and advice. He He

@alex. PLEASE CONSIDER THERE ARE TWO SIDES OF A COIN.

@Ppmaster. Indeed. As I said before. Kanger is under promoter's control now. It's not affected by the fundamental or future prospects of Kanger.

It's worth for the medium or long run investors to invest and hold their shares. TAYOR

@wistlebower99. Can browse in BURSA website. Some of the said news should be there.

ASYIK MERUNGUT PUN TAK ADA GUNA. He He

https://www.bursamalaysia.com/market_information/announcements/company_announcement?company=0170

The progress report on TracAPM in the 4QR 2021 report:
..... On 24 March 2021, the Prime Minister Tan Sri Dato’ Haji Muhyiddin bin Haji Muhammad Yassin launched the TracAPM Digital System which solved the digitalisation of APM forces on-the-ground in handling the pandemic quarantine station, transportation, screening test and emergency response as well as handling of corpse due to Covid-19. ..... The system successfully solved the multi-agencies manual processes under one unified platform in the Kuala Lumpur International Airport (KLIA) since February 2021 for all travellers entering Malaysia, all kinds of quarantine tracking including hotel, government facilities and home quarantines.
...... The system further being implemented as pilot project in Sarawak for all International borders entries, as well as all domestic travel bubble entry points for Island of Langkawi, in KLIA, KLIA2, Subang, Ipoh, Johor and Sarawak airports, as well as Kuala Perlis Ferry Terminal, Kuala Kedah Ferry Terminal and other entry points in support of national endemic programs.


Another progress report on Healthcare and Logistic businesses in the 4QR 2021 report:

.... Over all group investment in healthcare continues to progress well with government project TracAPM and SafeTravelPass pandemic and endemic travellers entry-registration, payment and process management of Quarantine-Stations, home quarantines and government services contributing positively in current financial year.
....... COVID-19 tests partnership with government is looking at positive return in coming quarter after much capital investment, in view of taking part of mass screening assignment engaged with government health facilities during endemic economic and border openings. ....... Government project capital investment continue to weight on current quarter which is normal for concession early investment and The Group continue to invest further in line with government direction to push for economic and social recovery. ........ The healthcare segment had experienced lower margin and recent success in contracts shall expect to contribute to bottom line in coming quarters.
......... On the other bright side, the logistic segment saw the growing demand of port services post pandemic. The Group expect the coming quarters shall expect the recovery of business activities especially import and export segment related to port activities

For mid-term or long term investors in Kanger.
I think we better look at WB closely.

Is it worth to collect @ 0.5 sen as our mid-term investment or not ?

@mansaham1972. Saya dah set pelaburan Kanger sebagai sekurang-kurang mid-term investment. Masih percaya dengan prospek jangka sederhananya. .... Apa-apa pun TAYOR.

Satu lagi, penilaian pelabur yang hendak jadikan kaunter Kanger sebagai kaunter trading adalah berbeza dengan penilaian pelabur yang sanggup jadikan kaunter ini kaunter pelaburan mid-term atau long-term......

@mansaham1972. Soal harga akan turun berapa tu saya tak boleh komen. Saya rasa komen awak pun macam komen saya dibuat atas dasar andaian dan pandangan peribadi sahaja.

Namun, untuk isu consolidation tu, saya selalu kemukakan kemungkinan risiko yang rendah untuk Kanger, terutama buat masa terdekat atau jangka sederhana ini. Alasannya atas dasar "SEMUA SYARIKAT MEMPUNYAI RISIKO UNTUK MEMBUAT KONSOLIDASI SAHAM". Tetapi risiko untuk itu adalah berbeza untuk setiap syarikat.

Maaf.

Reasoning yang banyak kali saya kemukakan di forum ini fasal risiko konsolidasi saham yang dihadapi oleh Kanger. Bagi saya, risiko untuk buat konsolidasi adalah rendah.
----------

I JUST WANT TO TAKE SOME POSITIVE NOTES ON THIS BIG PERCENTAGE OF SHAREHOLDING BY SUBSTANTIAL SHARE HOLDERS IN KANGER.

1. All those three substantial shareholders already took up 1,795,552,215 units of shares or 32.32 % of shareholding in Kanger.

2. Even the NOSH has been lifted up to 5,978,812,213, the share spread among retail investors was not getting widen.

3. The big shareholding among a few substantial investors give me more confidence on the company management and prospect.

4. Consider Sii Tung Nai (from Sung Master) as a substantial holder in Kanger. His reputation on managing Sung Master, an unlisted company with good results (as reported). Hope Kanger can get some good direction in managing the company for a better businesses.

----------------------------------
In general, share consolidation is perceived negatively, especially by investors. When investors see the stock price plummet, share consolidation will be seen as an accounting tactic to save the image of a company that is not performing well. As a result, they usually sell the company's shares, which eventually brings down the price again.

DO YOU THINK AFTER INVESTING A LOT AND BEEN THE SUBSTANTIAL SHAREHOLDERS OF KANGER, THEY INTEND TO DO CONSOLIDATION IN THE SHORT TERM PERIOD?????

ARE THEY THE FOOLISH INVESTORS???

@mansaham1972. Terima kasih saja. Dalam pelaburan saham semua cakap dari pihak lain TAK BOLEH 100% PERCAYA...

Awak pun bukan guru saham, saya pun selalu buat banyak silap dalam pelaburan saham. Malah laporan dari syarikat pun bukan 100% boleh percaya.

At last, kena guna penilaian sendiri. Kaji sendiri sesuatu saham, buat kesimpulan dan ambil keputusan sendiri. Risiko sendiri tanggung.

Cuma, kita kena awasi setiap orang yang memberi komen dalam forum ini pun mempunyai KEPENTINGAN SENDIRI.. Kita boleh share, gunakan logik dan fakta.

Akhirnya TAYOR.